Drilon, A;
Siena, S;
Dziadziuszko, R;
Barlesi, F;
Krebs, MG;
Shaw, AT;
de Braud, F;
... Doebele, RC; + view all
(2020)
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials.
The Lancet Oncology
, 21
(2)
pp. 261-270.
10.1016/S1470-2045(19)30690-4.